Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
Sponsored by University of South Florida
About this trial
Last updated 16 years ago
Study ID
MINI-KID Validation Study
Status
Completed
Type
Observational
Placebo
No
Accepting
6 to 17 Years
All
Trial Timing
Ended 17 years ago
What is this trial about?
The primary aims of this study are to assess:
1. The inter-rater and test-retest reliability of the MINI-KID
2. The validity of the standard MINI-KID interview in relation to the parent rated
pencil/paper version (MINI-KID-P) and th longer clinician rated "Schedule for
Affective Disorders and Schizophrenia for School Aged Children-Present and Lifetime
Version (K-SADS-PL) and "expert opinion" (when available).
Secondary aims will include evaluating the concordance between: The Children's Global
Assessment Scale (a required part of the K-SADS) with the clinician-rated Sheehan
Disability Scale (to be administered with the MINI-KID) as a measure of illness severity.
What are the participation requirements?
Inclusion Criteria
- Subjects will be between the ages of 6 years and 17 years, 11 months
- All subjects must meet MINI-KID DSM-IV criteria for a least one of the Axis I child psychiatry disorders covered by the MINI-KID.
- Both sexes are included.
Exclusion Criteria
- Subjects who suffer from mental retardation, significant developmental disorders, congenital abnormalities, delirium, dementia, a language problem, or brain damage will be excluded.
- Subjects with neurological disorders, chronic or life threatening diseases will be excluded.